Lite Strategy (LITS) Stock Analysis
NASDAQHealthcareBiotechnology
What Lite Strategy does
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Key metrics
ETFs linked to LITS
Broad-market and Healthcare sector ETFs an investor holding Lite Strategy is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how LITS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze LITS in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Lite Strategy?
- Lite Strategy trades under the ticker LITS on NASDAQ.
- Which exchange is LITS listed on?
- LITS is listed on NASDAQ.
- What sector does Lite Strategy operate in?
- Lite Strategy is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze LITS in a portfolio?
- PortView shows LITS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.